As an alternative to unfractionated heparin and platelet glycoprotein IIb/IIIa antagonists
In vivo study
Bivalirudin (2 mg/kg) delays both the time for appearance of first thrombus and the time for occlusion in P2Y12 +/+ arteries, although neither prevented vessel occlusion.
